LEXINGTON, Ky. — The University of Kentucky will temporarily pause administering the Johnson & Johnson (J&J) COVID-19 vaccine at the Gatton Student Center, the university said Tuesday. The announcement comes after the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recommended that states pause using the J&J vaccine "out of an abundance of caution" after six recipients in the U.S. developed a rare disorder involving blood clots.

What You Need To Know

  • University of Kentucky temporarily pausing J&J vaccine

  • The announcement came after FDA and CDC recommended states pause using the vaccine

  • The university will continue to administer vaccines to those with appointments using the Pfizer two-shot vaccine

  • Anyone with questions may call UK Health Corps at 859-218-0111

The university said it will continue to administer vaccines to those with appointments using the Pfizer two-shot vaccine "until further guidance is issued by the federal government about J&J."

UK's other vaccine sites at Kroger Field, University Health Service, its retail pharmacy and mobile clinic sites already use either the Pfizer or Moderna vaccines.

"As more information becomes available, UK and health officials will move quickly to communicate the latest details, acting always in the best interests of the health and safety of the community," said a release from the university.

Anyone with questions may call UK Health Corps at 859-218-0111.

Related Stories